DIFFERENTIAL REGULATION OF PROTOONCOGENES C-JUN AND C-FOS IN T-LYMPHOCYTES ACTIVATED THROUGH CD28

被引:0
|
作者
CHATTA, GS
SPIES, AG
CHANG, S
MIZE, GJ
LINSLEY, PS
LEDBETTER, JA
MORRIS, DR
机构
[1] UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195
[2] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[3] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
来源
JOURNAL OF IMMUNOLOGY | 1994年 / 153卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The T cell surface molecule CD28 binds to ligands on accessory cells and APCs, playing an important costimulatory role in the response of T cells to Ags. Our knowledge of the intracellular signaling pathways coupled to this receptor is incomplete. In addition to activation of phospholipase C gamma 1, ligation of this receptor also seems to activate a calcium-independent, CD28-specific pathway. In this paper, we report that cross-linking of CD28 (but not CD2, CD5, LFA-1, or CD7) leads to an elevation of c-jun mRNA, with only minimal activation of c-fos expression. CD28-dependent induction of c-jun expression requires protein tyrosine kinase activity, but does not depend on activation of a phorbol ester-responsive protein kinase C or elevation of cytosolic calcium. Further more, CD28-dependent elevation of c-jun mRNA does not appear to be mediated at the level of mRNA stability. A mechanism is suggested whereby expression of c-jun and junB, in the absence of members of the fos family, can prevent inappropriate activation of T cells caused by ligation of CD28 in the absence of a specific antigenic stimulus.
引用
收藏
页码:5393 / 5401
页数:9
相关论文
共 50 条
  • [41] Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars
    Teofoli, P
    Barduagni, S
    Ribuffo, M
    Campanella, A
    De Pita, O
    Puddu, P
    JOURNAL OF DERMATOLOGICAL SCIENCE, 1999, 22 (01) : 31 - 37
  • [42] DIOXIN INDUCES EXPRESSION OF C-FOS AND C-JUN PROTOONCOGENES AND A LARGE INCREASE IN TRANSCRIPTION FACTOR AP-1
    PUGA, A
    NEBERT, DW
    CARRIER, F
    DNA AND CELL BIOLOGY, 1992, 11 (04) : 269 - 281
  • [43] CD28 is not required for c-Jun N-terminal kinase activation in T cells
    Rivas, FV
    O'Herrin, S
    Gajewski, TF
    JOURNAL OF IMMUNOLOGY, 2001, 167 (06): : 3123 - 3128
  • [44] Differential regulation of inducible transcription factors c-fos and c-jun mRNA in spinal cord following surgical inflammation
    Dolan, S
    Huan, M
    Kelly, JG
    Nolan, AM
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U59 - U59
  • [45] DECREASED EXPRESSION OF PROTOONCOGENES C-FOS, C-MYC, AND C-JUN FOLLOWING POLYAMINE DEPLETION IN IEC-6 CELLS
    WANG, JY
    MCCORMACK, SA
    VIAR, MJ
    WANG, HL
    TZEN, CY
    SCOTT, RE
    JOHNSON, LR
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (02): : G331 - G338
  • [46] Transcriptional up-regulation of the protooncogenes c-fos and c-jun following vitreous removal and short-term in vitro culture of bovine lenses
    Chiapponi, C
    Carta, A
    Petrucco, S
    Maraini, G
    Ottonello, S
    EXPERIMENTAL EYE RESEARCH, 2001, 72 (05) : 565 - 571
  • [47] DOWN-REGULATION OF HUMAN ALPHA-FETOPROTEIN PROMOTER BY C-JUN AND C-FOS
    SAEGUSA, M
    IDO, A
    NAKABAYASHI, H
    SAKAI, M
    TAMAOKI, T
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1994, 9 (01): : 29 - 34
  • [48] DIVERGENT REGULATION OF THE HUMAN ATRIAL-NATRIURETIC-PEPTIDE GENE BY C-JUN AND C-FOS
    KOVACICMILIVOJEVIC, B
    GARDNER, DG
    MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (01) : 292 - 301
  • [49] Expression of c-Myc, c-Fos, and c-Jun in hepatocellular carcinoma
    Yuen, MF
    Wu, PC
    Lai, WCH
    Lau, JYN
    Lai, CL
    CANCER, 2001, 91 (01) : 106 - 112
  • [50] c-Jun和c-Fos及其与人类肿瘤
    郭光明
    王明荣
    国外医学遗传学分册., 2005, (04) : 207 - 211